Evaluation of chemotherapy treatments used in colorectal cancer therapy: A narrative review
DOI:
https://doi.org/10.33448/rsd-v11i8.30388Keywords:
Antineoplastic agents; Colorectal neoplasm; Health teaching; Neoadjuvant therapy.Abstract
Colorectal cancer is the fourth neoplasm in number of deaths in the world. It affects thousands of people, often diagnosed at a late stage, making a cure impossible. Therefore, we seek to adapt the treatments already known, as well as to develop new forms of therapies. The objective of this research was to find recent studies that sought to evaluate the different therapies used for colorectal cancer. Methodology: A bibliographic review was carried out, where the articles searched were searched in the Pubmed database, using keywords. Results: Twenty articles were analyzed for the construction of the review. Conclusion: Among the studies found by this review, it is clear that some have very encouraging results in relation to new treatments for colorectal cancer, but they need further research, increasing, for example, the number of participants. The biggest problem about the treatment of intestinal cancer is still the late diagnosis and the toxicity/safety of the therapies used, and some studies have stopped to research them, trying to find ways to reduce the side effects in the patient, improving their well-being.
References
Aisu, N., Yoshida, Y., Komono, A., Sakamoto, R., Kojima, D., & Hasegawa, S. (2019). Phase 2 study of perioperative chemotherapy with SOX and surgery for stage III colorectal cancer (SOS3 study). Scientific Reports, 9(1), 1-7.
Araujo‐Mino, E. P., Patt, Y. Z., Murray‐Krezan, C., Hanson, J. A., Bansal, P., Liem, B. J., ... & Lee, F. C. (2018). Phase II trial using a combination of oxaliplatin, capecitabine, and celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer. The oncologist, 23(1), 2-e5.
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017). Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66(4), 683-691.
Brambilla, E., Ponte, M. D., Ruschel, L. G., Bosi, H. R., Braga, G. L. D., & Silva, P. G. D. (2012). Staging of colorectal cancer in the private service versus Brazilian National Public Health System: what has changed after five years?. Journal of Coloproctology (Rio de Janeiro), 32, 144-147.
Campos, F.G.C.M.; Regadas, F. S. P.; Pinho, M. (2012) Tratado de coloproctologia. 1. ed. São Paulo: Atheneu.
Ciseł, B., Pietrzak, L., Michalski, W., Wyrwicz, L., Rutkowski, A., Kosakowska, E., ... & Polish Colorectal Study Group. (2019). Long-course preoperative chemoradiation versus 5× 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Annals of Oncology, 30(8), 1298-1303.
Coimbra, F. J. F., Pires, T. C., da Costa Junior, W. L., Diniz, A. L., & de Castro Ribeiro, H. S. (2011). Avanços no tratamento cirúrgico das metástases hepáticas colorretais. Revista da Associação Médica Brasileira, 57(2), 220-227.
CORDEIRO, Alexander Magno et al. Systematic review: a narrative review. Revista do colégio Brasileiro de Cirurgiões, v. 34, p. 428-431, 2007.
De Bari, B., Franzetti-Pellanda, A., Saidi, A., Biggiogero, M., Hahnloser, D., Montemurro, M., ... & Ozsahin, M. (2019). Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series. Journal of cancer research and clinical oncology, 145(4), 1075-1084.
Deng, Y., Chi, P., Lan, P., Wang, L., Chen, W., Cui, L., ... & Wang, J. (2019). Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. Journal of Clinical Oncology, 37(34), 3223.
Foletto, E. F., Jackisch, S. E., Dotto, M. L., Severo, C., Pappen, E., de Moura Valim, A. R., ... & Possuelo, L. G. (2016). Therapeutic itinerary of colorectal cancer patients treated in the state of Rio Grande do Sul. Journal of Coloproctology (Rio de Janeiro), 36, 91-96.
Gollins, S., West, N., Sebag-Montefiore, D., Susnerwala, S., Falk, S., Brown, N., ... & Hurt, C. (2018). A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British journal of cancer, 119(6), 697-706.
Golo, D., But-Hadzic, J., Anderluh, F., Brecelj, E., Edhemovic, I., Jeromen, A., ... & Velenik, V. (2018). Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer-long-term results of phase II OIGIT-01 Trial. Radiology and oncology, 52(3), 267-274.
IARC – International Agency for Research on Cancer. Cancer Tomorrow. Disponível em: https://gco.iarc.fr/tomorrow. Acesso em: 25 de Dezembro de 2021
Jia, A. Y., Narang, A., Safar, B., Zaheer, A., Murphy, A., Azad, N. S., ... & Meyer, J. (2019). Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma. Radiation Oncology, 14(1), 1-6.
Khoo, E., O'Neill, S., Brown, E., Wigmore, S. J., & Harrison, E. M. (2016). Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases. Hpb, 18(6), 485-493.
Kitz, J., Fokas, E., Beissbarth, T., Ströbel, P., Wittekind, C., Hartmann, A., ... & German Rectal Cancer Study Group. (2018). Association of plane of total mesorectal excision with prognosis of rectal cancer: secondary analysis of the CAO/ARO/AIO-04 phase 3 randomized clinical trial. JAMA surgery, 153(8), e181607-e181607.
Kogler, P., DeVries, A. F., Eisterer, W., Thaler, J., Sölkner, L., & Öfner, D. (2018). Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer. Strahlentherapie und Onkologie, 194(1), 41-49.
Lee, S. W., Lee, J. H., Lee, I. K., Oh, S. T., Kim, D. Y., Kim, T. H., ... & Jang, H. S. (2018). The impact of surgical timing on pathologic tumor response after short course and long course preoperative chemoradiation for locally advanced rectal adenocarcinoma. Cancer Research and Treatment: Official Journal of Korean Cancer Association, 50(3), 1039.
Leichman, C. G., McDonough, S. L., Smalley, S. R., Billingsley, K. G., Lenz, H. J., Beldner, M. A., ... & Hochster, H. S. (2018). Cetuximab combined with induction oxaliplatin and capecitabine, followed by neoadjuvant chemoradiation for locally advanced rectal cancer: SWOG 0713. Clinical colorectal cancer, 17(1), e121-e125.
Levidou, G., Saetta, A. A., Gigelou, F., Karlou, M., Papanastasiou, P., Stamatelli, A., ... & Korkolopoulou, P. (2012). ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World journal of surgical oncology, 10(1), 1-11.
Marco, M. R., Zhou, L., Patil, S., Marcet, J. E., Varma, M. G., Oommen, S., ... & Timing of Rectal Cancer Response to Chemoradiation Consortium. (2018). Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: final results of a multicenter phase II trial. Diseases of the colon and rectum, 61(10), 1146.
Nishimura, J., Hasegawa, J., Kato, T., Yoshioka, S., Noura, S., Kagawa, Y., ... & Mori, M. (2018). Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer. Cancer chemotherapy and pharmacology, 82(4), 707-716.
Räsänen, M., Renkonen-Sinisalo, L., Mustonen, H., & Lepistö, A. (2019). Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study. World Journal of Surgical Oncology, 17(1), 1-7.
Rother, E. T. (2007). Systematic literature review X narrative review. Acta paulista de enfermagem, v. 20, p. v-vi,
Sanoff, H. K., Moon, D. H., Moore, D. T., Boles, J., Bui, C., Blackstock, W., ... & Wang, A. Z. (2019). Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer. Nanomedicine: Nanotechnology, Biology and Medicine, 18, 189-195.
Wang, Y., Shen, L., Wan, J., Zhang, H., Wu, R., Wang, J., ... & Xia, F. (2022). Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH). BMC cancer, 22(1), 1-8.
Wang, J., Guan, Y., Gu, W., Yan, S., Zhou, J., Huang, D., ... & Zhu, J. (2019). Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002). Radiation Oncology, 14(1), 1-9.
Yang, Y., Liu, Q., Jia, B., Du, X., Dai, G., Liu, H., ... & Feng, L. (2019). Preoperative volumetric modulated Arc therapy with simultaneous integrated boost for locally advanced distal rectal cancer. Technology in Cancer Research & Treatment, 18, 1533033818824367.
Yu, X., Wang, Q. X., Xiao, W. W., Chang, H., Zeng, Z. F., Lu, Z. H., ... & Gao, Y. H. (2018). Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study. Cancer Communications, 38(1), 1-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Emelin Pappen; Morgana Pappen; Cássia Regina Alves Mendes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
